Cargando…
Delayed anti-VEGF injections during the COVID-19 pandemic and changes in visual acuity in patients with three common retinal diseases: A systematic review and meta-analysis
The COVID-19 pandemic disrupted the regular injections of anti-vascular endothelial growth factor (anti-VEGF) in patients with various retinal diseases globally. It is unclear to what extent delayed anti-VEGF injections have worsened patients’ visual acuity. We performed a meta-analysis to assess th...
Autores principales: | Im, James H.B., Jin, Ya-Ping, Chow, Ronald, Dharia, Riddhi Shah, Yan, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374495/ https://www.ncbi.nlm.nih.gov/pubmed/35970234 http://dx.doi.org/10.1016/j.survophthal.2022.08.002 |
Ejemplares similares
-
Visual Acuity and Retinal Disease
Publicado: (1907) -
Retinal and cortical visual acuity in a common inbred albino mouse
por: Braha, Michelle, et al.
Publicado: (2021) -
Flavoprotein Fluorescence Correlation with Visual Acuity Response in Patients Receiving Anti-VEGF Injection for Diabetic Macular Edema
por: Andrade Romo, Jorge S., et al.
Publicado: (2018) -
Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
por: Wecker, Thomas, et al.
Publicado: (2019) -
Retinal Vascular Resistance Significantly Correlates With Visual Acuity After 1 Year of Anti-VEGF Therapy in Central Retinal Vein Occlusion
por: Matsumoto, Makiko, et al.
Publicado: (2021)